2012
DOI: 10.2147/ijn.s26601
|View full text |Cite
|
Sign up to set email alerts
|

In vitro placental model optimization for nanoparticle transport studies

Abstract: Advances in biomedical nanotechnology raise hopes in patient populations but may also raise questions regarding biodistribution and biocompatibility, especially during pregnancy. Special consideration must be given to the placenta as a biological barrier because a pregnant woman's exposure to nanoparticles could have significant effects on the fetus developing in the womb. Therefore, the purpose of this study is to optimize an in vitro model for characterizing the transport of nanoparticles across human placen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
36
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 50 publications
(41 citation statements)
references
References 30 publications
3
36
0
Order By: Relevance
“…Previously, we have shown minimal passage (less than 1%) of smaller (20 nm) AgNPs across a monolayer of Caco-2/M-cells exposed for 4 h (Bouwmeester et al 2011). For larger AgNPs it can be expected that the passage/transport is lower, in addition, we currently used membranes with a smaller pore size that might hinder the transport of the AgNPs (Cartwright et al 2012). However, in vivo studies indicate that silver can reach the systemic circulation, as oral feeding studies with rodents have reported low oral bioavailability of silver after exposure to AgNPs of different sizes (Loeschner et al 2011;van der Zande et al 2012).…”
Section: Discussionmentioning
confidence: 99%
“…Previously, we have shown minimal passage (less than 1%) of smaller (20 nm) AgNPs across a monolayer of Caco-2/M-cells exposed for 4 h (Bouwmeester et al 2011). For larger AgNPs it can be expected that the passage/transport is lower, in addition, we currently used membranes with a smaller pore size that might hinder the transport of the AgNPs (Cartwright et al 2012). However, in vivo studies indicate that silver can reach the systemic circulation, as oral feeding studies with rodents have reported low oral bioavailability of silver after exposure to AgNPs of different sizes (Loeschner et al 2011;van der Zande et al 2012).…”
Section: Discussionmentioning
confidence: 99%
“…Menjoge et al reported low but quantifiable transfer of polyamidoamine dendrimers from maternal to fetal perfusate (Menjoge et al 2011). On the other hand, the transplacental transport of polystyrene NPs has been observed in both BeWo cells and in perfused placenta, and in both cases, the transport was shown to be size-dependent (Wick et al 2010; Cartwright et al 2012). …”
Section: Discussionmentioning
confidence: 99%
“…After 2 h of horizontal shaking (200 rpm) at 37°C, 100 μL lysate samples were analyzed for fluorescence to quantify NP uptake and attachment to the cells. The apparent permeability P e of the NPs across the cell monolayer was calculated as previously described in Cartwright et al (2012).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Because nanoparticles have properties, such as an extremely small size (less than 100 nm in diameter), high surface area per mass ratio and high potential chemical activities, adverse health effects from the daily application of nanoparticles have been seriously considered [5, 9, 10, 24, 32, 34]. The fetus is known to be susceptible to various toxic substances [1, 15, 39].…”
mentioning
confidence: 99%